Purple Biotech Ltd.
PPBT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614744
No open-market purchases or sales by Purple Biotech Ltd. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $141.0K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Purple Biotech Ltd. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +1 vs. Q1 2023
- Shares held
- 277.5K
- +152.3K (+121.6%) vs. Q1 2023
- Total value
- $388.3K
- +$164.0K (+73.2%) vs. Q1 2023
- New holders
- 5
- 4 more added
- Sold out
- 4
- 2 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PPBT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $141.0K |
| Q1 2026 | 15 | $305.6K |
| Q4 2025 | 19 | $513.2K |
| Q3 2025 | 16 | $75.9K |
| Q2 2025 | 14 | $133.7K |
| Q1 2025 | 9 | $134.3K |
| Q4 2024 | 14 | $377.9K |
| Q3 2024 | 11 | $946.1K |
| Q2 2024 | 21 | $775.9K |
| Q1 2024 | 21 | $1.77M |
| Q4 2023 | 20 | $1.90M |
| Q3 2023 | 18 | $275.9K |
| Q2 2023 | 17 | $388.3K |
| Q1 2023 | 16 | $224.2K |
| Q4 2022 | 15 | $238.6K |
| Q3 2022 | 11 | $224.0K |
| Q2 2022 | 14 | $310.2K |
| Q1 2022 | 14 | $1.77M |
| Q4 2021 | 13 | $4.09M |
| Q3 2021 | 12 | $5.27M |
| Q2 2021 | 13 | $3.72M |
| Q1 2021 | 15 | $2.40M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Purple Biotech Ltd.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kingswood Wealth Advisors, LLC | 127,950 | $178.5K | 0.06% | +127,950 | New |
| Citadel Advisors LLC | 45,944 | $64.3K | 0.00% | +30,769+202.8% | Added |
| Morgan Stanley | 29,632 | $41.3K | 0.00% | +6,544+28.3% | Added |
| Venture Visionary Partners LLC | 13,718 | $19.1K | 0.00% | +650+5.0% | Added |
| Wealth Advisors of Iowa, LLC | 13,270 | $18.5K | 0.01% | +765+6.1% | Added |
| Geode Capital Management, LLC | 12,666 | $17.7K | 0.00% | 00.0% | Unchanged |
| Raymond James & Associates | 11,000 | $15.3K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 9,158 | $12.0K | 0.00% | −10,545−53.5% | Reduced |
| Fiduciary Alliance LLC | 5,410 | $7.55K | 0.00% | +5,410 | New |
| TD Waterhouse Canada Inc. | 4,000 | $7.37K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 3,370 | $4.72K | 0.00% | −10.0% | Reduced |
| Rhumbline Advisers | 555 | $777 | 0.00% | +555 | New |
| Global Retirement Partners, LLC | 336 | $469 | 0.00% | +336 | New |
| North Star Investment Management Corp. | 300 | $418 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 50 | $70 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 22 | $31 | 0.00% | +22 | New |
| Royal Bank of Canada | 108 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 0 | $0 | 0.00% | −4,566−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −2,600−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −1,995−100.0% | Sold out |
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |